132
Participants
Start Date
February 27, 2024
Primary Completion Date
February 15, 2028
Study Completion Date
March 15, 2028
This study is with minimal risk and minimal constraints due to the addition of questionnaires
"In this study, the specific procedures compared to routine care are :~* Considering the addition of questionnaires, this study will be prospective. Due to the use of bacteriological samples, it is considered as a minimal-risk research.~* The research procedure involves a bacteriological analysis of operative elements (sutures placed during the first intervention, the product of tendon debridement, and the subacromial bursa (cleaning product)) used during the re-intervention. These usually discarded operative samples are collected for bacteriological analysis.~* Antibiotic treatment cannot be prescribed immediately after the surgery and during the first month following this re-intervention (time for biofilm formation). As per the protocol, even a positive sample should not lead to the initiation of systematic antibiotic therapy. In the case of identification of a pathogenic microorganism, antibiotic therapy will be prescribed, leading to discontinuation of the study."
NOT_YET_RECRUITING
Hôpital privé Saint-Martin, Caen
NOT_YET_RECRUITING
Clinique d'occitanie ELSAN, Muret
NOT_YET_RECRUITING
Santé Atlantique ELSAN, Saint-Herblain
NOT_YET_RECRUITING
Clinique Louis Pasteur, Essey-lès-Nancy
NOT_YET_RECRUITING
Hôpital privé La Châtaigneraie ELSAN, Beaumont
NOT_YET_RECRUITING
Santy-Lyon-Ramsay, Lyon
NOT_YET_RECRUITING
ICR-Kantys, Nice
RECRUITING
Clinique de l'Orangerie, Strasbourg
Lead Sponsor
Elsan
OTHER